Beijing Beilu Pharmaceutical Co Ltd

Chart & Performance

D1W1MN

P/E

51.37

P/S

3.98

EPS

0.16

Div Yield, %

0.63%

Shrs. gr., 5y

1.31%

Rev. gr., 5y

6.85%

Revenues

1.20b

+21.74%

Net income

93m

+579.29%

CFO

177m

+8.47%

Dividend

May 19, 20250.05 CNY/sh

Notes

No notes on this company yet

Write a private note on this company, for your eyes only

Profile

Beijing Beilu Pharmaceutical Co., Ltd., established in 1992 and headquartered in Beijing, China, operates within the pharmaceutical industry. The company is primarily involved in the research, development, production, and commercialization of diverse medicinal products. Its offerings notably include specialized drugs like contrast agents, treatments for central nervous system conditions, and oral medications designed for diabetes. Additionally, Beilu Pharmaceutical also ventures into the manufacturing of precision medicine.

URL

http://www.beilu.com.cn

IPO date

Oct 30, 2009

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title CNY in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY	FY
Title CNY in thousands, except ratios and share amounts	2025‑12	2024‑12	2023‑12	2023‑00	2022‑12	2022‑00	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT